米非司酮联合中药治疗子宫肌瘤的疗效观察  

The Efficacy of Mifepristone Combined with Traditional Chinese Medicine in Treatment of Uterine Fibroids

作　　者：周俊红[1,2] 王红艳[3] 

机构地区：[1]湖北省黄梅县骨科医院 [2]黄梅卫校,湖北黄梅435500 [3]湖北省黄梅县人民医院,湖北黄梅435500

出　　处：《中国现代医生》2011年第31期73-74,共2页China Modern Doctor

摘　　要：目的探讨米非司酮联合中药治疗子宫肌瘤的疗效。方法入院确诊的70例子宫肌瘤患者随机分为治疗组(米非司酮+中药)和对照组(米非司酮)各35例,比较两组治疗的临床疗效及治疗前后血红蛋白、瘤体体积的变化。结果两组间疗效比较,治疗组的疗效优于对照组(P<0.01)。治疗后两组的血红蛋白均较治疗前明显升高,瘤体体积治疗后均较治疗前明显降低(P<0.01)。两组血红蛋白及瘤体体积比较,治疗组的血红蛋白及瘤体体积较对照组改善更明显,差异有统计学意义(P<0.05)。结论米非司酮联合中药治疗子宫肌瘤可显著提高临床疗效,能够明显缩小瘤体体积,值得推广和应用。Objective To investigate the effects of mifepristone combined with traditional Chinese medicine in treatment of uterine fibroids. Methods Seventy cases were randomly divided into treatment group （mifepristone ＋ medicine） and control group （mifepristone） with 35 cases in each in our hospital from February 2009 to February 2010, and the clinical efficacy and the changes of hemoglobin, tumor volume were comparde before and after treatment. Results The two groups were compared, the efficacy of treatment group was significantly higher than control group, and the difference was statistically significant （P 〈 0.01 ）. After treatment, the hemoglobin was significantly higher than that before treatment, tumor volume after treatment was significantly lower than that before treatment （ P 〈 0.01 ） .Two groups hemoglobin and tumor volume was improved more significantly than the control group, the difference was statistically significant （P〈0.05）. Conclusion Mifepristone and traditional Chinese medicine treatment uterine fibroids can significantly improve the clinical efficacy and reduce the tumor size. It is shouldbe promoted and applied.

关 键 词：子宫肌瘤 米非司酮 中药 血红蛋白 

分 类 号：R711.74[医药卫生—妇产科学]